Variant report

Variant	esv3331416
Chromosome Location	chr2:127962771-127980988
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:276)
CpG islands
(count:1220)
Chromatin interactive
region (count:10)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:276 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr2:127978469-127978928	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr2:127976536-127976757	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr2:127977021-127977221	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr2:127978610-127978921	H1-hESC	embryonic stem cell:	n/a	n/a
5	CEBPB	chr2:127978408-127978681	A549	lung:	n/a	n/a
6	CEBPB	chr2:127974884-127975840	Hela-S3	cervix:	n/a	n/a
7	CEBPB	chr2:127978350-127978767	H1-hESC	embryonic stem cell:	n/a	n/a
8	CEBPB	chr2:127978376-127978690	HepG2	liver:	n/a	n/a
9	CEBPB	chr2:127964619-127964663	K562	blood:	n/a	n/a
10	CHD1	chr2:127977925-127978781	H1-hESC	embryonic stem cell:	n/a	n/a
11	CHD1	chr2:127976706-127977050	H1-hESC	embryonic stem cell:	n/a	n/a
12	CHD2	chr2:127975550-127975833	Hela-S3	cervix:	n/a	n/a
13	CHD2	chr2:127976626-127976629	H1-hESC	embryonic stem cell:	n/a	n/a
14	CHD2	chr2:127966010-127966272	Hela-S3	cervix:	n/a	n/a
15	CHD2	chr2:127978295-127978965	H1-hESC	embryonic stem cell:	n/a	n/a
16	CHD2	chr2:127966057-127966280	H1-hESC	embryonic stem cell:	n/a	n/a
17	CREB1	chr2:127975536-127975824	A549	lung:	n/a	n/a
18	CTBP2	chr2:127976359-127977309	H1-hESC	embryonic stem cell:	n/a	n/a
19	CTBP2	chr2:127978461-127978935	H1-hESC	embryonic stem cell:	n/a	n/a
20	CTCF	chr2:127976500-127976650	SK-N-SH_RA	brain:	n/a	chr2:127976619-127976635 chr2:127976618-127976636
21	CTCF	chr2:127977880-127978030	NHEK	skin:	n/a	n/a
22	CTCF	chr2:127976520-127976670	HMEC	breast:	n/a	chr2:127976618-127976636 chr2:127976619-127976635
23	CTCF	chr2:127976480-127976630	AG04449	skin:	n/a	n/a
24	CTCF	chr2:127976500-127976650	BJ	skin:	n/a	chr2:127976619-127976635 chr2:127976618-127976636
25	CTCF	chr2:127975460-127975610	HMEC	breast:	n/a	chr2:127975534-127975552
26	CTCF	chr2:127977320-127977470	HRE	kidney:	n/a	n/a
27	CTCF	chr2:127977080-127977230	HRE	kidney:	n/a	chr2:127977149-127977158
28	CTCF	chr2:127977320-127977470	HMEC	breast:	n/a	n/a
29	CTCF	chr2:127976580-127976730	HBMEC	blood vessel:	n/a	chr2:127976619-127976635 chr2:127976618-127976636
30	CTCF	chr2:127965640-127965790	HRE	kidney:	n/a	n/a
31	CTCF	chr2:127976580-127976730	HEEpiC	esophagus:	n/a	chr2:127976619-127976635 chr2:127976618-127976636
32	CTCF	chr2:127965640-127965790	HMEC	breast:	n/a	n/a
33	CTCF	chr2:127976400-127976550	HMEC	breast:	n/a	n/a
34	CTCF	chr2:127976420-127976570	A549	lung:	n/a	n/a
35	CTCF	chr2:127963140-127963290	HBMEC	blood vessel:	n/a	n/a
36	CTCF	chr2:127967258-127967361	LNCaP	prostate:	n/a	n/a
37	CTCF	chr2:127976534-127976575	Kidney_OC	kidney:	n/a	n/a
38	CTCF	chr2:127977380-127977530	AG04449	skin:	n/a	n/a
39	CTCF	chr2:127965680-127965830	HEK293	kidney:	n/a	n/a
40	CTCF	chr2:127976760-127976910	AG04449	skin:	n/a	chr2:127976889-127976898 chr2:127976889-127976902
41	CTCF	chr2:127963180-127963330	NHEK	skin:	n/a	n/a
42	CTCF	chr2:127975380-127975530	A549	lung:	n/a	n/a
43	CTCF	chr2:127976409-127976539	NHEK	skin:	n/a	n/a
44	CTCF	chr2:127976456-127976468	A549	lung:	n/a	n/a
45	CTCF	chr2:127977840-127977990	SK-N-SH_RA	brain:	n/a	n/a
46	CTCF	chr2:127976457-127976498	MCF-7	breast:	n/a	n/a
47	CTCF	chr2:127976560-127976710	HUVEC	blood vessel:	n/a	chr2:127976619-127976635 chr2:127976618-127976636
48	CTCF	chr2:127976418-127976522	Fibrobl	skin:	n/a	n/a
49	CTCF	chr2:127968296-127968336	LNCaP	prostate:	n/a	n/a
50	CTCF	chr2:127977920-127978070	A549	lung:	n/a	n/a

(count:1220 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:127963512-127963562	HCT-116	colon:	n/a
2	chr2:127963653-127963703	PFSK-1	brain:	n/a
3	chr2:127976928-127976978	HIPEpiC	eye:	n/a
4	chr2:127964374-127964424	CMK	blood:	n/a
5	chr2:127963590-127963640	AG10803	skin:	n/a
6	chr2:127963503-127963553	GM12892	blood:	n/a
7	chr2:127963489-127963539	SKMC	muscle:	n/a
8	chr2:127976613-127976663	Jurkat	blood:	n/a
9	chr2:127978490-127978540	GM12892	blood:	n/a
10	chr2:127963067-127963117	SK-N-SH	brain:	n/a
11	chr2:127977385-127977435	K562	blood:	n/a
12	chr2:127977559-127977609	ECC-1	luminal epithelium:	n/a
13	chr2:127976351-127976401	HCF	heart:	n/a
14	chr2:127977849-127977899	K562	blood:	n/a
15	chr2:127963503-127963553	HCF	heart:	n/a
16	chr2:127976351-127976401	Caco-2	colon:	n/a
17	chr2:127977559-127977609	ovcar-3	ovarian:	n/a
18	chr2:127978490-127978540	NB4	blood:	n/a
19	chr2:127977849-127977899	ProgFib	skin:	n/a
20	chr2:127963590-127963640	MCF-7	breast:	n/a
21	chr2:127963512-127963562	MCF-7	breast:	n/a
22	chr2:127963653-127963703	HPAEpiC	pulmonary alveolar:	n/a
23	chr2:127963330-127963380	AG04449	skin:	fetal
24	chr2:127963489-127963539	GM19239	blood:	n/a
25	chr2:127963653-127963703	HCF	heart:	n/a
26	chr2:127963512-127963562	AG09319	gingival:	n/a
27	chr2:127975738-127975788	AG09319	gingival:	n/a
28	chr2:127978490-127978540	NHDF-neo	bronchial:	n/a
29	chr2:127978579-127978629	HIPEpiC	eye:	n/a
30	chr2:127975738-127975788	HRPEpiC	eye:	n/a
31	chr2:127963067-127963117	PANC-1	pancreas:	n/a
32	chr2:127963330-127963380	K562	blood:	n/a
33	chr2:127963489-127963539	ProgFib	skin:	n/a
34	chr2:127977385-127977435	ProgFib	skin:	n/a
35	chr2:127976613-127976663	HCM	heart:	n/a
36	chr2:127975738-127975788	HRCEpiC	kidney:	n/a
37	chr2:127976400-127976450	CMK	blood:	n/a
38	chr2:127978579-127978629	SK-N-MC	brain:	n/a
39	chr2:127963489-127963539	Hela-S3	cervix:	n/a
40	chr2:127976738-127976788	HIPEpiC	eye:	n/a
41	chr2:127977385-127977435	HUVEC	blood vessel:	n/a
42	chr2:127963590-127963640	T-47D	breast:	n/a
43	chr2:127963067-127963117	U87	brain:	n/a
44	chr2:127975738-127975788	HRE	kidney:	n/a
45	chr2:127973314-127973364	AG09309	skin:	n/a
46	chr2:127976400-127976450	GM12892	blood:	n/a
47	chr2:127963590-127963640	HCT-116	colon:	n/a
48	chr2:127963489-127963539	AoSMC	blood vessel:	n/a
49	chr2:127963653-127963703	SK-N-MC	brain:	n/a
50	chr2:127977559-127977609	HAEpiC	amniotic membrane:	n/a

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:127975205..127977314-chr2:127992465..127995136,2	K562	blood:
2	chr2:127957550..127959520-chr2:127975505..127977152,2	MCF-7	breast:
3	chr2:127961531..127964078-chr2:127974115..127976124,2	MCF-7	breast:
4	chr2:127965809..127968370-chr2:127982231..127984174,2	K562	blood:
5	chr2:127974300..127976848-chr2:127983797..127985574,2	MCF-7	breast:
6	chr11:67195868..67198192-chr2:127980594..127982880,2	MCF-7	breast:
7	chr2:127976448..127978493-chr2:127980576..127983526,3	MCF-7	breast:
8	chr2:127973375..127977110-chr2:128049967..128052200,3	MCF-7	breast:
9	chr2:127978350..127980779-chr2:127984214..127985920,2	MCF-7	breast:
10	chr2:127972542..127975941-chr2:127982453..127985678,4	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ERCC3-1	chr2:127975143-127976209	ucscGeneNc_uc002too_1

No data

Variant related genes	Relation type
CYP27C1	TF binding region
CYP27C1	CpG island
ENSG00000186684	chromatin interactions
ENSG00000175634	chromatin interactions
ENSG00000163161	chromatin interactions

Extended variants
information (count: 615 )
Associated
traits (count: 56 )

Variant overlapped rSNPs/rCNVs (count:615 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs74597038	chr2:127962782-127962783	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs546122433	chr2:127962814-127962815	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs114333617	chr2:127962858-127962859	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs575788689	chr2:127962867-127962868	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs183154308	chr2:127962920-127962921	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs377149468	chr2:127962921-127962922	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs530160153	chr2:127962932-127962933	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs546661093	chr2:127962949-127962950	Enhancers Weak transcription Genic enhancers Strong transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs79927691	chr2:127963004-127963005	Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Strong transcription Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs116770675	chr2:127963071-127963072	Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Strong transcription Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs552789956	chr2:127963093-127963094	Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Strong transcription Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs141493748	chr2:127963096-127963097	Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Strong transcription Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs143653373	chr2:127963127-127963128	Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers Strong transcription Bivalent/Poised TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs75071675	chr2:127963268-127963269	Enhancers Active TSS Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs530541740	chr2:127963282-127963283	Enhancers Active TSS Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs201801731	chr2:127963360-127963361	Enhancers Active TSS Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription Flanking Active TSS Bivalent Enhancer	CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs533909828	chr2:127963395-127963396	Enhancers Active TSS Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs566452293	chr2:127963415-127963416	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs35035604	chr2:127963424-127963425	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs397706131	chr2:127963428-127963429	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs542473932	chr2:127963454-127963455	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs115224999	chr2:127963473-127963474	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs567239357	chr2:127963490-127963491	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs536004169	chr2:127963532-127963533	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs539067847	chr2:127963567-127963568	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs148123964	chr2:127963591-127963592	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Genic enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs575951382	chr2:127963714-127963715	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs140981336	chr2:127963735-127963736	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs564810865	chr2:127963746-127963747	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs187686401	chr2:127963768-127963769	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs36163071	chr2:127963771-127963772	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs574580858	chr2:127963772-127963773	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs113483266	chr2:127963775-127963776	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs150147760	chr2:127963800-127963801	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs72517050	chr2:127963867-127963868	Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs532496296	chr2:127963872-127963873	Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs112555400	chr2:127963884-127963885	Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs571084754	chr2:127963888-127963889	Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs562391125	chr2:127963895-127963896	Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs563148568	chr2:127963961-127963962	Weak transcription Strong transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs373921188	chr2:127964003-127964004	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs141868407	chr2:127964028-127964029	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs568713658	chr2:127964109-127964110	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs533650824	chr2:127964112-127964113	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs192647714	chr2:127964244-127964245	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs146260708	chr2:127964278-127964279	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs530127692	chr2:127964294-127964295	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs137888213	chr2:127964296-127964297	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs555912566	chr2:127964325-127964326	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs78597087	chr2:127964341-127964342	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:56)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Mental retardation	17621639	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Medulloblastoma	16968546	CNVD
Neurocytoma	17123091	CNVD
Developmental delay	21147756	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:731 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:127934600-127965600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr2:127941000-127963000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr2:127948800-127973400	Weak transcription	HMEC	breast
4	chr2:127951200-127965800	Weak transcription	Esophagus	oesophagus
5	chr2:127952000-127963000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
6	chr2:127952200-127964400	Weak transcription	Right Atrium	heart
7	chr2:127952200-127975200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
8	chr2:127954200-127964000	Strong transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
9	chr2:127954600-127962800	Weak transcription	HUES64 Cell Line	embryonic stem cell
10	chr2:127954800-127965600	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr2:127955000-127965600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
12	chr2:127955600-127962800	Weak transcription	Brain Hippocampus Middle	brain
13	chr2:127955800-127963000	Weak transcription	HUES48 Cell Line	embryonic stem cell
14	chr2:127956400-127975800	Weak transcription	Fetal Kidney	kidney
15	chr2:127957400-127965800	Weak transcription	NHEK	skin
16	chr2:127957800-127963200	Weak transcription	Fetal Intestine Small	intestine
17	chr2:127959200-127963000	Weak transcription	Fetal Muscle Leg	muscle
18	chr2:127959400-127963000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
19	chr2:127959400-127965800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
20	chr2:127959600-127963000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
21	chr2:127961000-127963200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr2:127961200-127965800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
23	chr2:127961400-127965800	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr2:127961800-127963000	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr2:127962200-127962800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
26	chr2:127962200-127963000	Enhancers	Fetal Lung	lung
27	chr2:127962400-127962800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
28	chr2:127962400-127963200	Enhancers	Fetal Brain Male	brain
29	chr2:127962400-127963400	Enhancers	ES-I3 Cell Line	embryonic stem cell
30	chr2:127962400-127963400	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
31	chr2:127962400-127963600	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr2:127962400-127963600	Enhancers	Placenta	Placenta
33	chr2:127962400-127963600	Genic enhancers	Fetal Stomach	stomach
34	chr2:127962600-127963000	Enhancers	Fetal Brain Female	brain
35	chr2:127962600-127963600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
36	chr2:127962600-127963800	Enhancers	HUES6 Cell Line	embryonic stem cell
37	chr2:127962600-127965600	Weak transcription	H1 Cell Line	embryonic stem cell
38	chr2:127962800-127963200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr2:127962800-127963400	Enhancers	Brain Hippocampus Middle	brain
40	chr2:127962800-127963600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
41	chr2:127962800-127963800	Enhancers	HUES64 Cell Line	embryonic stem cell
42	chr2:127963000-127963200	Enhancers	HUES48 Cell Line	embryonic stem cell
43	chr2:127963000-127963200	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
44	chr2:127963000-127963200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
45	chr2:127963000-127963200	Enhancers	Fetal Muscle Leg	muscle
46	chr2:127963000-127963400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
47	chr2:127963000-127963400	Enhancers	iPS-18 Cell Line	embryonic stem cell
48	chr2:127963000-127963400	Flanking Active TSS	Fetal Lung	lung
49	chr2:127963000-127963600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
50	chr2:127963000-127963600	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links